Dysregulated angiogenesis may play a significant role in COPD, with pulmonary vascular remodeling potentially involving a dynamic process characterized by elevated vascular endothelial growth factor (VEGF) expression in the early stages and reduced levels in later stages [19]. This evidence concerns the gene VEGFA and chronic obstructive pulmonary disease.